OPI SA LAUNCHES HUNTINGTON'S DISEASE DRUG IN FRANCE

Cambridge Laboratories, a specialist pharmaceuticals company, has announced that its partner, OPi SA, has launched Xenazine 25mg (tetrabenazine) in France, following publication in the "Journal Officiel" of its reimbursement price that has been granted by the authorities. Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34885§ionid=)